- Home
- STKE vs NTHI Comparison
STKE vs NTHI Comparison
Compare STKE & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKE
- NTHI
- Stock Information
- Founded
- STKE 2002
- NTHI 2008
- Country
- STKE
- NTHI United States
- Employees
- STKE N/A
- NTHI N/A
- Industry
- STKE
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- STKE
- NTHI Health Care
- Exchange
- STKE Nasdaq
- NTHI Nasdaq
- Market Cap
- STKE 162.8M
- NTHI 155.4M
- IPO Year
- STKE N/A
- NTHI N/A
- Fundamental
- Price
- STKE N/A
- NTHI $10.49
- Analyst Decision
- STKE
- NTHI
- Analyst Count
- STKE 0
- NTHI 0
- Target Price
- STKE N/A
- NTHI N/A
- AVG Volume (30 Days)
- STKE 463.2K
- NTHI 82.3K
- Earning Date
- STKE 01-29-2026
- NTHI 08-19-2025
- Dividend Yield
- STKE N/A
- NTHI N/A
- EPS Growth
- STKE N/A
- NTHI N/A
- EPS
- STKE N/A
- NTHI N/A
- Revenue
- STKE $14,342,517.00
- NTHI $59,990.00
- Revenue This Year
- STKE N/A
- NTHI N/A
- Revenue Next Year
- STKE N/A
- NTHI N/A
- P/E Ratio
- STKE N/A
- NTHI N/A
- Revenue Growth
- STKE N/A
- NTHI N/A
- 52 Week Low
- STKE $0.65
- NTHI $3.20
- 52 Week High
- STKE $34.32
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- STKE N/A
- NTHI N/A
- Support Level
- STKE N/A
- NTHI N/A
- Resistance Level
- STKE N/A
- NTHI N/A
- Average True Range (ATR)
- STKE 0.00
- NTHI 0.00
- MACD
- STKE 0.00
- NTHI 0.00
- Stochastic Oscillator
- STKE 0.00
- NTHI 0.00
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").